Ducommun NYSE: DCO reported record second-quarter revenue as growth in commercial aerospace and military programs lifted sales, margins and earnings. The company said it remains on track to meet its full-year revenue outlook despite expecting lower growth rates in the second half after pulling forward some production activity into the first half.
Ducommun Incorporated (DCO) Q2 2026 Earnings Call Transcript
Ducommun (DCO) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $0.88 per share a year ago.
| Aerospace & Defense Industry | Industrials Sector | Stephen G. Oswald CEO | XDUS Exchange | US2641471097 ISIN |
| US Country | 2,130 Employees | 4 Mar 2011 Last Dividend | 11 Jun 1998 Last Split | - IPO Date |
Ducommun Incorporated stands as a pivotal engineering and manufacturing service provider with a focus on the aerospace and defense, industrial, medical, and numerous other sectors within the United States. The company's offerings are spread across two critical segments: Electronic Systems and Structural Systems. With a history dating back to 1849 and having its headquarters nestled in Santa Ana, California, Ducommun has etched its name as a reliable partner for delivering sophisticated and high-quality solutions tailored to meet the demanding specifications of its clients' projects.
Ducommun Incorporated boasts a broad spectrum of products and services delivered through its Electronic Systems and Structural Systems segments, catering to various industries and applications.
This segment is synonymous with an array of high-tech electronic components and assemblies crucial for aerospace, defense, and other specialized market applications. Key offerings include:
Focusing on the structural integrity and component manufacture for aerospace and other applications, this segment includes:
Its clientele spans across commercial and military aerospace sectors, including both fixed-wing and rotary-wing aircraft, as well as space programs. The segment also caters to industrial, medical, and additional markets, demonstrating the company's versatile manufacturing capability.